Filing Details
- Accession Number:
- 0001062993-23-018551
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-09-27 20:50:14
- Reporting Period:
- 2023-09-20
- Accepted Time:
- 2023-09-27 20:50:14
- Original Submission Date:
- 2023-09-22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1799011 | Lucid Diagnostics Inc. | LUCD | () | 4/A |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1678195 | Stanley Lapidus | 360 Madison Avenue, 25Th Floor New York NY 10017 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-09-20 | 3,405 | $1.45 | 132,051 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-09-20 | 412 | $1.44 | 131,639 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-09-21 | 100 | $1.44 | 131,539 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.
- Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023.
- The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023.